Elsevier

Brain Research

Volume 454, Issues 1–2, 28 June 1988, Pages 275-281
Brain Research

Morphometric immunochemical analysis of neurons in the nucleus basalis of Meynert in Alzheimer's disease

https://doi.org/10.1016/0006-8993(88)90827-XGet rights and content

Abstract

In Alzheimer's disease there is a reported loss of large cells in the cholinergic nucleus basalis of Meynert. It has been suggested, however, that there may be neurons in the nucleus basalis in Alzheimer's disease which are atrophied and therefore difficult to distinguish form neuroglia by size. This has important therapeutic implications and we have attempted to clarify the situation using a neuron-specific antiserum directed against neuron-specific enolase (NSE). Sections of nucleus basalis were stained using this antiserum and the neuronal cross-sectional area was measured. A profile of neuronal distribution with area was obtained, by image analysis, and compared in controls and patients with Alzheimer's disease. A significant 29% overall loss of neurons was found in Alzheimer's disease with a much greater loss (61%) of large neurons and concurrent increase (59%) in small neurons. Analysis of variance showed significant reduction in mean cross-sectional neuronal area as a consequence of this shift in frequency towards a preponderance of small cells. It is suggested that in the nucleus basalis in Alzheimer's disease, large neurons are not completely lost; many are shrunken and thus excluded from the previous studies of large cells counted in Nissl-stained material. That there is partial preservation of these neurons makes it more likely that cholinergic dysfunction, characteristic of Alzheimer's disease, will be amenable to neurotrophic influence.

References (40)

  • PearsonR.C.A. et al.

    The cholinergic nuclei of the basal forebrain of the rat: hypertrophy following contralateral cortical damage or section of the corpus callosum

    Brain Research

    (1987)
  • RinneJ.O. et al.

    Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease

    J. Neurol. Sci.

    (1987)
  • SeilerM. et al.

    Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat

    Brain Research

    (1984)
  • SofroniewM.V. et al.

    Retrograde changes in cholinergic neurons in the basal forebrain of the rat following cortical damage

    Brain Research

    (1983)
  • SofroniewM.V. et al.

    The cholinergic nuclei of the basal forebrain of the rat: normal structure, development and experimentally induced degeneration

    Brain Research

    (1987)
  • TagliaviniF. et al.

    Basal nucleus of Meynert. A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntingdon's chorea

    J. Neurol. Sci.

    (1983)
  • AppelS.H.

    A unifying hypothesis for the cause of amylotrophic lateral sclerosis, Parkinsonism and Alzheimer's disease

    Ann. Neurol.

    (1981)
  • ArendtT. et al.

    Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease

    Acta Neuropathol.

    (1983)
  • BowenD.M. et al.

    Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

    Brain

    (1976)
  • CrossR.B.

    Demonstration of neurofibrillary tangles in paraffin sections—a quick and simple method using a modification of Palmgren's method

    Med. Lab. Sci.

    (1982)
  • Cited by (75)

    • Neural pathway from nucleus basalis of Meynert passing through the cingulum in the human brain

      2010, Brain Research
      Citation Excerpt :

      Many studies have reported on cognitive impairment in patients who showed pathology in the NBM and its related cholinergic pathways; these patients had various diseases, such as aneurysm rupture in the anterior communicating artery, traumatic brain injury, or some form of neurologic dementia (Allen et al., 1988; Benke et al., 2005; Bigl and Arendt, 1991; Chozick, 1987; Murdoch et al., 2002; Rogers et al., 1985). However, except for post-mortem brain study, there has been no specific method of evaluation for the NBM and its cholinergic pathway (Allen et al., 1988; Benke et al., 2005; Murdoch et al., 2002). In the past, identification and visualization of the subcortical neural tract in the live human brain was impossible.

    View all citing articles on Scopus
    View full text